Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants orthospinenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orthospinenews.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, presented its plans for.
Share this article
PARSIPPANY, N.J., April 29, 2021 /PRNewswire/ In celebration of Patient Experience Week (April 26-30, 2021),
Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, today announced ongoing growth and adoption of its patient-centric innovations. These solutions are designed to help improve patient outcomes and experiences using the latest in precision anatomic modeling, 3D printing, design innovation, and workflow optimization. All are intended to help address the clinical challenges of individual surgeons and patients with these complex orthopaedic conditions.
Instilling precision and patient-centricity from pre-operative planning through surgery, Onkos is bringing welcomed innovation to musculoskeletal oncology and complex orthopaedics. Last year alone, the Company launched three new solutions that build upon its innovations in implant design and pre-op planning the ELEOS™ Proximal Femoral Replac
Onkos Surgical :® continues its innovation in musculoskeletal oncology and complex orthopaedic reconstruction with the launch of the ELEOS™ Proximal Tibia with BioGrip™ technology marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.